Other signaling cascades involved in CLL pathogenesis, in particular NOTCH signaling and NF-kB signaling, already provide biomarkers for a precision medicine approach to CLL and may represent potential druggable targets for the future. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.